Cannabidiol as a Prophylactic Agent Against Glioblastoma Growth: A Preclinical Investigation
Abstract Glioblastoma (GBM) remains one of the most lethal brain tumors, with current therapies offering limited benefits and high relapse…
Bidhan Bhandari
Rethinking Alzheimer’s: Harnessing Cannabidiol to Modulate IDO and cGAS Pathways for Neuroinflammation Control
Abstract Alzheimer’s disease (AD) has traditionally been associated with amyloid-β plaques, but growing evidence underscores the role of neuroinflammation in…
Optimization of seizure prevention by cannabidiol (CBD)
Abstract Objective: Cannabidiol (CBD) is one of the most prominent non-psychotropic cannabinoids with known therapeutic potentials. Based on its anti-seizure…
Boosting Acetylcholine Signaling by Cannabidiol in a Murine Model of Alzheimer’s Disease
Abstract Alzheimer’s disease (AD) is a challenging medical issue that requires efficacious treatment options to improve long-term quality of life.…